Synnovation Therapeutics is a precision oncology company that develops therapeutics that aims to help people with cancer.
Synnovation Therapeutics has raised $102.0M in total funding. The most recent round was Series A. The last funding was announced in December 2023.
Synnovation Therapeutics's investors include Cormorant Asset Management, Lilly Asia Ventures, Third Rock Ventures, Nextech Invest, Sirona Capital.
Synnovation Therapeutics is headquartered in Wilmington, United States.
Synnovation Therapeutics is a precision oncology company that develops therapeutics that aims to help people with cancer.
Synnovation Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Synnovation Therapeutics — Funding & Investors." VCBacked, December 14, 2023, https://www.vcbacked.co/company/synnovation-therapeutics. Accessed July 19, 2026.
VCBacked. (2023). Synnovation Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/synnovation-therapeutics
{{cite web |title=Synnovation Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/synnovation-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated